AEON Biopharma, Inc. (AEON)
AEON Biopharma was planning to go public, but the IPO has been withdrawn.
Stock Price: $14.00 - $16.00
Current IPO price range
Total Valuation
AEON Biopharma has a market cap or net worth of $329.94 million. The enterprise value is $398.68 million.
Market Cap | 329.94M |
Enterprise Value | 398.68M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
AEON Biopharma has 22.00 million shares outstanding.
Shares Outstanding | 22.00M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 292.76 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 353.75 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of n/a, with a Debt / Equity ratio of n/a.
Current Ratio | n/a |
Quick Ratio | 1.20 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $187,833 |
Profits Per Employee | -$8.90M |
Employee Count | 6 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (1Y) | n/a |
Total Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Average Volume (30 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AEON Biopharma had revenue of $1.13 million and -53.41 million in losses. Earnings per share was -$2.43.
Revenue | 1.13M |
Gross Profit | 1.13M |
Operating Income | -54.47M |
Net Income | -53.41M |
EBITDA | -53.41M |
EBIT | -53.41M |
Earnings Per Share (EPS) | -$2.43 |
Balance Sheet
The company has $10.61 million in cash and $79.34 million in debt, giving a net cash position of -$68.74 million or -$3.12 per share.
Cash & Cash Equivalents | 10.61M |
Total Debt | 79.34M |
Net Cash | -68.74M |
Net Cash Per Share | -$3.12 |
Book Value | -207.66M |
Book Value Per Share | -9.44 |
Working Capital | 8.62M |
Cash Flow
Operating Cash Flow | -19.96M |
Capital Expenditures | n/a |
Free Cash Flow | -19.96M |
FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -4,833.01% and -4,738.86%.
Gross Margin | 100.00% |
Operating Margin | -4,833.01% |
Pretax Margin | n/a |
Profit Margin | -4,738.86% |
EBITDA Margin | -4,738.78% |
EBIT Margin | -4,738.78% |
FCF Margin | -1,770.81% |
Dividends & Yields
AEON Biopharma does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -16.19% |
FCF Yield | -6.05% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |